Evidence map›Paper›PMID 36430784›Full record

ArticleInternational journal of molecular sciences2022

In Vitro Production of Galactooligosaccharides by a Novel β-Galactosidase of

Alexander Arsov, Ivan Ivanov, Lidia Tsigoriyna, Kaloyan Petrov, Penka Petrova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Food science & nutrition · 2026
    Review
  5. Article
  6. Characterization of a β-Galactosidase fromMolecules (Basel, Switzerland) · 2025
    Article
  7. A NewFoods (Basel, Switzerland) · 2025
    Article
  8. Review
  9. Review
  10. Galacto-oligosaccharide production byJDS communications · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander ArsovInstitute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0003-4733-9530
Ivan IvanovInstitute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0003-3173-9871
Lidia TsigoriynaInstitute of Chemical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-6123-2719
Kaloyan PetrovInstitute of Chemical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-9197-0894
Penka PetrovaInstitute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.ORCID 0000-0001-7356-5799
Bulgarian Academy of Sciences · BG

Funding

Bulgarian Ministry of Education and Science "Healthy Foods for a Strong Bio-Economy and Quality of Life" National Research Programme approved by DCM # 577/17.08.2018EU CA 18101
6 · The paper itself

Abstract

β-galactosidase is an enzyme with dual activity and important industrial application. As a hydrolase, the enzyme eliminates lactose in milk, while as a trans-galactosidase it produces prebiotic galactooligosaccharides (GOS) with various degrees of polymerization (DP). The aim of the present study is the molecular characterization of β-galactosidase from a Bulgarian isolate,

Indexed as

Lactobacillus delbrueckiiAnimalsbeta-GalactosidaseEscherichia coliLactoseMilkbeta-GalactosidaseLactoseLactobacillus bulgaricusprebioticβ-galactosidase

Identifiers

PMID36430784
PMCPMC9697242
OpenAlexW4309458584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.